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Abstract	  
Background 
Hereditary membranopathies are important red blood cell (RBC) disorders, however, diagnosis 
can be challenging in mild cases for which osmotic fragility tests yield normal results. The 
diagnostic gold standard under these conditions is osmotic gradient ektacytometry. Since the 
diagnosis of hereditary membranopathies influences patient management, a screening test 
might be of value. 
Design and Methods 
Since the percentage of hyperchromic RBCs is routinely measured by many hematologic 
laboratories, we evaluated the predictive value of an elevated percentage of hyperchromic RBCs 
for the detection of RBC disorders. We did an extensive workup of all patients undergoing 
standard hematogram during a period of six months at our institution with a fraction of 
hyperchromic RBC larger than 10% by reviewing the medical history and performing osmotic 
gradient ektacytometry. 
Results 
32’226 individuals were screened of which 162 (0.5%) showed more than 10% hyperchromic 
RBC. All of these patients which could be examined by ektatocytometry showed abnormal 
membrane deformability. Hereditary spherocytosis (HS) was found in a third of these patients, in 
most cases unknown to the patient and currently asymptomatic. Another 17.9% of the patients 
with an elevated subpopulation of hyperchromic RBC suffered from a known viral infection (HIV, 
Hepatitis). 
Conclusions 
Our study shows that a proportion of hyperchromic erythrocytes larger than 10% is associated 
with RBC membrane disorders in a third of patients and further follow up should be considered. 
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Introduction  
Hereditary spherocytosis (HS) is a common form of hereditary red blood cell (RBC) 
membranopathies. Symptoms range from asymptomatic forms to occasional severe diseases 
requiring splenectomy and regular transfusions; a large portion of asymptomatic patients are 
unaware of their condition1. Due to the much shortened life time of erythrocytes, HS is a 
contraindication for blood donation in Switzerland2 and most developed countries. Therefore, 
screening for asymptomatic forms of HS might improve the effect of blood transfusions. 
HS is typically diagnosed by osmotic fragility testing3, however, mild forms of hereditary RBC 
membranopathies with only limited hemolytic activity are often difficult to identify4. In these 
cases, osmotic fragility tests have a poor sensitivity and about 20% of mild cases of HS are 
missed5. In contrast to this, osmotic gradient ektacytometry with the simultaneous recording of 
deformability against the solute concentration remains the gold standard for the diagnosis of 
altered erythrocyte deformability1,6. However, this assay is technically challenging and therefore 
not a suitable screening test. 
Hyperchromasia of red blood cells has been described in many red blood cell membranopathies, 
especially HS7. While in clinical practice frequently beside the morphology of RBC only the mean 
cellular hemoglobin concentration (MCHC) is considered, in our experience an elevated 
percentage of hyperchromic RBC even in the absence of an elevated MCHC can be predictive 
for an altered RBC membrane8. In addition to RBC membranopathies, erythrocytic 
hyperchromasia can also be caused by autoimmune hemolytic anemia (AIHA), acute oxidant 
injury, micro- and macroangiopathic hemolytic anemias, hemolytic transfusion reactions, 
thermal injuries, liver disease, clostridial sepsis, zinc toxicity, poisoning by certain snake, spider 
and hymenoptera venoms, severe hypophosphatemia, hypersplenism7, artificial heart valves, 
massive myocardial infarction and cytotoxic treatment9. Furthermore, pseudohyperchromasia 
due to an artifact of the automatic determination of the RBC indices can be caused by severe 
hypoosmolality of the plasma10.  
Hyperchromasia might therefore be a sign of a red blood cell membranopathy or a systemic 
disease. The percentage of hyperchromic red blood has been used before as a screening tool for 
RBC-membranopathies11, however, in this study no rigorous follow up of patients was 
attempted and the diagnostic significance of an elevated percentage of hyperchromic RBCs 
remains unclear. We therefore started a systematic investigation of all patients with marked 
elevation of hyperchromic RBC and ektatocytometry was used as a diagnostic tool for RBC-
membranopathies. In our study in almost a third of all patients with >10% hyperchromic 
erythrocytes membranopathies were identified, making the percentage of hyperchromic 
erythrocytes a useful screening tool for RBC membranopathies and follow up by 
ektatocytometry worthwhile. 
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Design and Methods 
Comparing the percentage of hyperchromic RBCs and MCHC during two months 
In order to evaluate the distribution of the percentage of hyperchromic RBCs and MCHC in our 
patient population we assessed all patients undergoing standard hematogram at the central 
hematologic laboratory of the university hospital in Zürich within a period of two months. If 
samples of a patient were measured on several occasions, only the sample with the highest 
percentage of hyperchromic RBC was considered. All hematograms where analyzed by an 
ADVIA 120 (Siemens, Germany). Erythrocytes with a corpuscular hemoglobin concentration of 
more than 41 g/dl are considered as hyperchromic, whereas the upper limit for the mean 
corpuscular hemoglobin concentration (MCHC) is defined as 36 g/dl. 
Patient recruitment and data collection 
From all patients undergoing a standard hematogram during a period of 6 months (February 
until August 2008), we selected all individuals with 10% or more hyperchromic erythrocytes. 
The medical history of these patients was reviewed and patients were classified as discussed 
below (Fig. 2). An elevated proportion of hyperchromic RBC in patients with one ore more 
known reasons for an acquired disease (see introduction) was considered “acquired”. If a 
hereditary membranopathy such as HS explaining the elevated fraction of hyperchromic 
erythrocytes had been diagnosed before, the patient was categorized as “known congenital”. 
All other patients were classified as having an “unknown” condition. Medical chart review 
revealed evidence for viral infections such as hepatitis B or C or human immunodeficiency virus 
(HIV) in many cases; therefore we divided "unknown" into two subgroups: Patients with 
documented viral infection and without. If the hyperchromic fraction had been in normal range 
at least once in the past (“not persistent”), the patient was excluded from further follow up. 
Even though an occasional presence of a normal fraction of hyperchromic erythrocytes in the 
patient’s history does not exclude a congenital cause with certainty, it at least makes a transient 
or acquired cause much more likely. For the remaining individuals (“possibly congenital”) a work 
up was done by determining the size of the spleen, performing a Coombs test and osmotic 
gradient ektacytometry on their RBC. For comparison and as internal controls we also tested 
several patients with “known congenital” hyperchromasia, documented viral infection and 
acquired reasons for hyperchromasia. 
Osmotic gradient ektacytometry 
RBC deformability was studied with an ektacytometer (Technikon, Bayer, Germany) in the 
osmoscan mode as described 6,12-14. Thereby, deformability of erythrocytes is measured by laser 
diffractometry. Deformability is plotted against the extracellular osmolality of a viscous solution 
of 20% dextran that provides a constant shear stress at increasing osmolality. Dextran had an 
average molecular weight of 70 kDa (Carl Roth GmbH, Germany), this solution further 
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contained 10 mM NaKHPO
4
 to minimize the effect of pH on deformability15, glucose (5.6 mM) 
and sodium azide (0.4 g/L). The osmolality gradient was obtained by adding sodium chloride to 
the solution in one compartment of the gradient mixer. The Technikon Ektacytometer measures 
conductivity of the RBC suspension close to the diffractometer. The system was calibrated 
beforehand by measuring ektacytometer’s conductivity on a series of solutions differing in 
osmolality by cryoscopic osmometry (Gonotec Osmomat 030). An aliquot of 500 µl whole 
blood, collected in a standard 10 ml BD K2H Vacutainer® (18.0 mg of K
2
EDTA), was mixed with 
3 ml of isoosmolal dextran solution and directly inserted into the Ektacytometer for 
measurement of RBC deformability. Blood samples were processed within 1-4 hours after 
donation and incubated at room temperature prior to mixing with dextran. All samples were 
measured twice, both values consistently showed an almost perfect correlation. The analog 
output of the Technikon Ektacytometer was digitalized using a 12 bit A/D-Converter (NI USB-
6008, National Instruments, USA). On the digitalized osmoscan obtained, the following points 
were calculated: P
max
 - the point of maximal deformability index (DI) and P
min
 - the point of 
minimal DI (in the hypoosmolal branch). In addition, the osmolalities where half the DI of P
max
 
was reached on both the hypoosmolal branch (P’A) and the hyperosmolal branch (P’B) were 
recorded (Fig. 3A). In order to compare results from patients and controls, we also recorded and 
analyzed osmoscans from 30 healthy volunteers. From these data an averaged osmoscan profile 
was calculated. The respective range (double standard deviation) of the four points P
min
, P
max
, P’A 
and P’B are indicated as boxes in the graphs (Fig. 3). These reference values were used for 
qualitative and quantitative evaluation of patients' samples. 
Determination of Pmin, Pmax, P’A and P’B for HS 
To acquire discriminatory values from osmoscans of HS patients, we reviewed 15 osmoscans 
from patients with known HS. Ten of these patients had a spectrin/ankyrin deficiency and five a 
band 3 deficiency as verified by SDS PAGE (not shown). The osmoscans had been obtained 
between 1999 and 2004 and were not digitalized but plotted onto paper. Therefore, the four 
characteristic points were determined manually from the plots. 
 
Ethical approval for this study was granted by the ethical committee of University Hospital 
Zurich.  All authors had access to the primary clinical data. 
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Results 
Comparing the percentage of hyperchromic RBCs and MCHC during two months 
In order to define an appropriate screening algorithm for RBC disorders we evaluated standard 
hematograms analyzed during a period of 2 months at our institution. 38'579 samples of 
14'988 individuals were tested. Overall, values obtained for MCHC and the percentage of 
hyperchromic erythrocytes correlated strongly (r=0.6, p<0.0001, spearman's rank correlation), 
Figure 1. Interestingly, this correlation was weaker at the extremes of both parameters (MCHC 
>36 g/dl and percentage of hyperchromatic RBCs >10%, not shown), confirming that MCHC 
and percentage of hyperchromatic RBCs cannot be used interchangeably. Of note, only 63% of 
the 40 patients with more than 10% or more hyperchromatic RBCs had an MCHC above the 
cut-off. Vice versa, only 14% of the 250 patients with a MCHC >36 g/dl had a percentage of 
hyperchromatic RBCs of 10% or above. Importantly, the frequency distribution of MCHC and 
the percentage of hyperchromatic erythrocytes was very different at the positive extremes of 
both curves. The distribution of both values did not follow a normal distribution (p<0.0001, 
D'Agostino and Pearson omnibus normality test). We chose an arbitrary cut-off value of 10% 
which would select approximately 0.3% of all patients. Such a cut-off value could be 
conveniently incorporated into routine praxis in our laboratory. 
Analysis of patients with more than 10% hyperchromic RBC 
In the observation period hematograms from 32.226 individual patients were analyzed at the 
Clinic of Hematology of the University Hospital of Zurich. Out of these samples, 162 (0.50%) 
contained more than 10% hyperchromic RBC (Fig. 2). Review of patients' records revealed an 
acquired reason for this finding in 37 patients (22.8%): A cytotoxic treatment was the most 
frequent condition identified, explaining the elevated hyperchromic fraction of RBC in 27 
patients; the 10 remaining patients summarized under the heading “other causes” included 
three with autoimmune hemolytic anemia (AIHA), three with severe plasma hypoosmolality, and 
one each with HELLP-syndrome (hemolysis, elevated liver enzymes, low platelets), an aortic valve 
defect, a massive myocardial infarction and recent surgery for aorto-coronary bypass. The group 
of patients with a “known congenital” explanation for the elevation of hyperchromic 
erythrocytes comprised 6 individuals (3.7%) including 5 patients with HS and one with 
hereditary cryohydrocytosis12, based on current and previous hematologic records at our 
hospital. For 119 patients (73.5%), classified as "unknown", we found no explanation for the 
elevated hyperchromic fraction. In these cases we either did not have access to a medical history 
or did not find evidence for any of the known reasons for hyperchromasia. Interestingly, 29 of 
these 119 patients were found to have acute or chronic viral infection, including 23 patients 
infected with HIV. For 23 of the remaining patients the percentage of hyperchromic RBC had 
been documented normal in the past ("not persistent"); in these cases we therefore postulated 
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an acquired cause. Finally, for a group of 66 patients, the elevation of the hyperchromic fraction 
was unexplained and likely to be persistent; in all probability this group would include patients 
with undiagnosed hereditary RBC membranopathies ("possibly congenital"). Laboratory findings 
of the different groups are shown in Table 1. 
Unexpectedly we found 8 patients suffering from epilepsy among the 119 patients with neither 
a known congenital nor an acquired membranopathy. 5 of these patients were classified as "not 
persistent", 2 as "possibly congenital" and one had a documented HIV-infection. Anticonvulsive 
treatment at the time of investigation could be confirmed in 6 of these patients by medical 
history including lamotrigine (2 patients), valproic acid (2 patients), carbamazepine (1 patient) 
and phenytoin (1 patient). 
Patients of the "possibly congenital" group as well as several members of the other groups were 
contacted for further testing. Ektacytometry could be performed on 32 subjects; four of these 
were of the “known congenital” group (three HS and one cryohydrocytosis) and were aware of 
their condition. Their osmoscans are shown in Fig. 3B, illustrating a mild case of HS, two 
pronounced cases of HS and one case of genetically confirmed cryohydrocytosis16. Sixteen of the 
remaining 28 patients examined by ektacytometry showed osmoscans characteristic for HS with 
14 displaying a mild and 2 a more pronounced form of HS (Fig. 3C). None of these patients had 
been diagnosed with HS before. 
Next we compared osmoscans of these newly diagnosed patients with osmoscans of previously 
described HS patients6 (Fig. 3D); the molecular defects in the latter individuals had been 
confirmed by SDS-PAGE demonstrating band 3 deficiencies (5 patients, black symbols) and 
spectrin/ankyrin deficiencies (10 patients, red symbols). Importantly, osmoscans of both groups 
showed virtually overlapping characteristics: i) a significantly decreased maximal deformability, ii) 
a lower surface to volume ratio, as indicated by a right shift of the left arm of the osmoscan and 
iii) an increase in MCHC (a loss of solutes) while reaching a non-deformable state at lower 
osmolality, apparent by a left shift of the right arm of the osmoscan. Therefore, it is not possible 
to differentiate HS resulting from different membrane defects by ektacytometry on whole blood. 
However, there is no doubt that the diagnosis for all patients whose osmoscans are shown in 
Fig. 3C and 3D is HS. 
In addition to HS, our analysis also revealed other characteristic osmoscan patterns; for example 
a group of four patients with "possibly congenital" elevation of the hyperchromic RBC fraction 
showed osmoscans in which the left arm was virtually identical to controls, but the right arm 
was shifted to lower osmolalities (Figure 3E). This pattern is highly similar to the osmoscans of 
two patients with documented viral infection as shown in Fig. 3F. The underlying 
pathophysiological reasons underlying this osmoscan pattern are unclear; since such a pattern 
seems to accompany several viral diseases we refer to it as a "viral pattern". 
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Furthermore, the remaining four tested patients assigned to the “possibly congenital” group 
had unique osmoscans, one fitting the diagnosis of dehydrated stomatocytosis17 (Fig. 3H, green 
line). The remaining three could not be assigned to a specific disorder (Fig 3H), pointing to as yet 
uncharacterized membranopathies or atypical presentations of known conditions. Interestingly, 
as shown in Fig. 3G, osmoscans of two patients with acquired reasons for hyperchromasia 
including one patient with AIHA and one after cytotoxic therapy also showed a characteristic 
pattern not shared by any other group. Importantly, none of the patients with >10% 
hyperchromic erythrocytes had a normal osmoscan pattern. 
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Discussion 
The majority of patients with more than 10% hyperchromic erythrocytes feature an elevated 
MCHC, however this correlation is not strict: More than a third show an MCHC within the 
normal range. Vice versa, an elevation of the MCHC is not strictly associated with a marked 
elevation of hyperchromic erythrocytes, indicating a certain independency of these parameters. 
Our data argue for the clinical value of an elevated fraction of hyperchromic RBCs as a screening 
parameter. If the percentage of hyperchromic RBCs is elevated to more than 10% and an 
acquired condition can be excluded, a further follow up including tests for viral infections and 
hereditary membranopathies should be considered. 
Among 32.226 patients undergoing a standard hematogram at the University Hospital of Zurich 
during a period of six months, we found 162 with more than 10% hyperchromic RBC. Patients 
were classified according to their medical history. In 23% of theses patients we found known 
acquired reasons and, unexpectedly, in 18% a viral infection. After excluding patients with only 
temporary elevations of the hyperchromic fraction, 66 patients (41%) of the original cohort 
remained as candidates for a congenital but so far undiagnosed RBC membrane disorder. In this 
study, 32 patients with an elevated fraction of hyperchromic erythrocytes were examined by 
ektacytometry and none of these patients revealed a normal pattern of RBC deformability. 
Among the patients with a possibly congenital condition we could investigate 24 by 
ektacytometry and found 16 osmoscans typical for HS (Fig. 3C). All of these patients presented 
without clinical symptoms of HS. Osmoscans allowed the classification into a mild form of HS 
(14 patients) and a pronounced form (2 patients). Comparisons of these osmoscans with those 
recorded from patients with known membrane protein deficiencies confirmed that all of these 
newly discovered patients have HS. 
According to our data, the prevalence of HS might be higher than generally estimated. 
Assuming, that the patients tested by ektacytometry would be representative for the “possibly 
congenital” patient group, the number of HS positive patients in this group can be extrapolated 
to be 44 (67%). Adding the 5 patients with previously known HS, the estimated number of HS 
patients within the 162 patients with hyperchromasia greater than 10% would be 49 (30%). 
The prevalence of HS in our collective of 32’226 patients can be calculated to be at least 1:650. 
Since the sensitivity of our screening test “hyperchromasia >10%” is not known, an unknown 
number of HS patients might have been missed by our study and the prevalence of HS would be 
even higher. In the literature, the prevalence of HS is usually estimated to be around 1:2’000, 
»including the very mild or subclinical forms« 1. Our data thus suggest an at least threefold 
higher prevalence, probably due to a large number of clinically silent cases of HS, which are 
never tested or missed by a more conventional analysis. However, it is not known, whether the 
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patient collective undergoing standard hematogram analysis at our institution is representative 
for the Swiss population. 
Interestingly, our screening test using the percentage of hyperchromic RBC also frequently 
revealed patients with viral infections. In fact, of the 119 patients with neither a known 
congenital membranopathy nor a condition for an acquired hyperchromasia, 29 (24%) had a 
documented viral infection, typically hepatitis or HIV. This is a strong indication that these viral 
infections can cause hyperchromasia. To the best of our knowledge, this association has not 
been described previously; One explanation for our finding would be an inhibition of 
erythropoiesis by certain viral infections, resulting in an over aged RBC population. For older 
RBCs membrane flexibility and cell water content would be decreased18,19, leading to an increase 
of the corpuscular hemoglobin concentration and of the fraction of hyperchromic cells. In 
agreement with this interpretation, the mean reticulocyte count was lowest in the group of 
patients with documented viral infections (Table 1), confirming the postulated a lower RBC turn 
over. 
Our analysis suggests that a simple test for hyperchromasia can identify individuals with 
contraindications for blood transfusion, thus potentially improving the quality of blood 
donations. In our study congenital RBC membranopathies which are considered 
contraindications for blood donations by several institutions2 were detected at a surprisingly high 
rate. Furthermore, some of the remaining patients suffered from viral infections including HIV 
and should also be excluded. However, any potential benefit of such an additional screening test 
can only be demonstrated by a prospective study. In our study, osmotic gradient ektacytometry 
has proven its reliability and sensitivity for the recognition and classification of RBC membrane 
disorders. The osmoscans of RBC from healthy donors only show minute variations (Fig. 3), 
whereas those of RBC from patients with an acquired or hereditary hyperchromasia show a 
broad spectrum of variance, depending on the cause of hyperchromasia. Importantly, some 
osmoscan patterns could not be attributed to any of the known RBC membranopathies, 
potentially pointing to as yet undiscovered red blood cell abnormalities or disorders. The 
considerably elevated spleen diameter (Table 2) found in patients of this group supports this 
hypothesis. A detailed follow up of these patients is in progress and might lead to new insights 
into RBC physiology. Taken together, our study suggests that a simple test for hyperchromasia 
can identify individuals with contraindications for blood transfusion. The use of this parameter 
could potentially improve the quality of blood donations. 
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Tables 
Table 1. Basic characteristics of patient groups.  
 units 
 (Reference) 
Acquired Congenital Unknown 
Cytotoxic Other  Not pers. 
Poss. 
cong. 
Viral 
No of 
patients 
 27 10 6 23 66 29 
Sex M:F 15:12 5:5 4:2 20:3 48:19 27:2 
Age years 54 (18-90) 
54 
(20-89) 
36 
(20-44) 
60 
(25-104) 
41 
(21-84) 
46 
(26-73) 
Hemoglobin g/dl (11.7-17.0) 
11.5 
(7.3-15.5) 
11.7 
(6.5-15.2) 
14.8 
(13.0-17.2) 
15.3 
(13.0-17.2) 
14.3 
(8.1-17.6) 
14.4 
(4.8-17.6) 
Reticulocytes ‰ (4-25) 
33.5 
(0.0-104.2) 
47.8 
(10.7-
151.6) 
23.4 
(15.0-39.4) 
24.3 
(5.7-56.4) 
29.4 
(9.4-123.0) 
18.7 
(4.8-44.3) 
MCHC g/dl (31-36) 
36.4 
(27.5-38.3) 
37.0 
(34.8-39.1) 
36.4 
(28.3-39.4) 
37.1 
(36.0-38.3) 
37.0 
(26.7-39.8) 
37.2 
(35.6-38.4) 
MCV fl (80-100) 
91.0 
(82.6-
101.0) 
85.7 
(80.6-92.8) 
82.8 
(76.7-85.9) 
86.2 
(79.0-98.4) 
85.2 
(25.3-98.4) 
90.5 
(39.6-
101.1) 
MCH pg (26-34) 
33.4 
(29.9-38.4) 
31.7 
(29.6-34.9) 
31.6 
(28.7-33.1) 
31.9 
(29.5-36.1) 
32.5 
(27.5-68.7) 
34.4 
(29.3-43.8) 
LDH U/l (240-420) 
477 
(224-791) 
1120 
(400-4656) 
449 
(357-546) 
531 
(240-1980) 
427 
(236-791) 
486 
(66-790) 
Bilirubine µMol/l (<21) 
93 
(7-819) 
39 
(6-109) 
33 
(27-39) 
15 
(4-31) 
15 
(5-36) 
33 
(9-80) 
Neutrophils 10
9/l 
(1.4-8.0) 
5.90 
(0.90-
20.30) 
12.65 
(2.10-
47.80) 
5.57 
(3.00-8.80) 
5.07 
(1.20-
19.10) 
5.58 
(0.50-
46.30) 
3.25 
(1.20-6.70) 
Lymphocytes 10
9/l 
(1.5-4.0) 
1.02 
(0.09-2.80) 
6.70 
(0.40-
54.70) 
2.36 
(1.19-5.24) 
1.37 
(0.34-4.16) 
2.53 
(0.54-
43.10) 
1.82 
(0.28-3.44) 
Thrombocytes 
109/l 
(143-400) 
216 
(35-471) 
173 
(34-310) 
386 
(196-851) 
207 
(71-366) 
243 
(32-547) 
186 
(28-366) 
The mean and the range of the observed values are indicated. 
 
Table 2. Characteristics of patients studied by ektacytometry. 
 (Reference) Viral Mild HS Pronounced HS Unknown 
No of patients  4 14 2 4 
Spleen diameter 
mm 
(<120) 
130 
(122-137) 
140 
(130-155) 
136 
(101-170) 
208 
(185-230) 
Reticulocytes ‰ (4-25) 
20 
(12-25) 
25 
(18-44) 
64 
(38-90) 
61 
(26-123) 
Hemoglobin g/dl (11.7-17.0) 
15.4 
(13.5-16.2) 
15.2 
(13.9-17.6) 
10.8 
(8.7-12.8) 
13.6 
(8.1-16.5) 
LDH U/l (240-420) 
382 
(314-449) 
373 
(343-398) 
531 
(492-570) 
543 
(308-778) 
Bilirubine µmol/l (<21) 
22 
(10-34) 
14 
(5-36) 
30 
(28-31) 
14 
(7-21) 
The mean and the range of the observed values are indicated  
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Figures 
Figure 1: Plot of MCHC as a function of the fraction of hyperchromic RBC. 
All patients undergoing standard hematogram analysis during a period of 2 months at our 
institution were included. The vertical lines indicate the upper and lower limits of normal 
(>36g/dl and <31g/dl, respectively). Similarly, the lower and upper reference values for the 
fraction of hyperchromic RBC (2% and 10%, respectively) are indicated as horizontal lines. The 
number of patients in each section of the plot is given. 
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Figure 2: Study design. 
During a period of six months all hematograms acquired were reviewed. For samples with more 
than 10% hyperchromic RBC patient records were analysed retrospectively. Patients with a 
known RBC disorder or a known condition leading to an elevation of hyperchromic RBCs were 
thus classified as having a “known congenital” or an “acquired” hyperchromasia. All other 
patients (“unknown”) were separated into patients “with documented viral infection” and 
without. Patients with a transient elevation of hyperchromic RBCs were excluded from follow up 
“not persistent”, the condition of the remaining patients was regarded as “possibly congenital”. 
Of these, 24 could be further examined by osmotic gradient ektacytometry. The resulting 
osmoscans followed four distinct patterns: (mild HS (14), pronounced HS (2), viral pattern (4), 
unknown patterns (4)). 
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Figure 3: Osmoscans. 
(A) Characteristic points of osmoscans. Pmin is the point of 50% hemolysis. Pmax is the 
point of maximal deformability. On the hyper- and hypoosmolal branches of the osmoscan, the 
osmolality at which half the maximal deformability (1/2 DI of Pmax) is reached are defined as P’A 
and correspondingly as P’B. (B) Patients with a known hereditary membranopathy of the 
RBC. Patients with known membranopathies were studied by ektacytometry. Three patients 
show different forms of HS (green), one patient has hereditary cryohydrocytosis (red). The 
ektacytometric features of HS consist of Pmax with deformability well below the normal range 
though at a normal osmolality, and often an increased osmolality of Pmin, indicating a 
diminished osmotic resistance. The osmolality of P’A is increased, whereas that of P’B is shifted 
to hypoosmolal conditions. Cryohydrocytosis has a different etiology, osmoscans show a 
reduced maximal deformability, a dramatically limited flexibility at high osmolality such that all 
characteristic points are shifted to hypoosmolality except for Pmin, which is shifted to 
hyperosmolality, again indicating a decreased osmotic resistance. For comparison, we added the 
mean curve of 30 healthy donors (blue) into all the following osmoscans. The blue boxes 
indicate the normal range of the four characteristic points Pmax, Pmin, P’A and P’B (double 
standard deviations). (C) Osmoscans of patients with “possibly congenital” elevation of 
the hyperchromic RBC-fraction revealing a pattern of HS. Fourteen patients’ osmoscans 
(red) reveal a mild form of HS, whereas 2 (purple) impress as more pronounced forms of HS. All 
osmoscans show the typical features of HS with a decreased maximal deformability and a loss of 
cellular solutes. The osmolality at which Pmin is reached is for the majority of cases only slightly 
higher than that of controls. This implies a minute reduction of the osmotic resistance and 
probably explains why all of these patients were asymptomatic. (D) Osmoscans of HS patients 
with SDS-PAGE confirmed membrane protein deficiencies. The black points originate from 
5 patients with band 3 deficiency, the red points from 10 patients with spectrin/ankyrin 
deficiency. The averages of the characteristic points for the two types of disorders are marked by 
asterixes in the corresponding colors. (E) Osmoscans from patients with “possibly 
congenital” elevation of the hyperchromic RBC-fraction revealing a viral pattern. Pmin 
and P’A are in the normal range, Pmax is slightly diminished and shifted to hypoosmolality, 
whereas P’B shows a clear shift to hypoosmolality. This solitary shift is characteristic for aged 
RBC that have lost solutes prematurely. The normal osmolality of Pmin indicates a normal 
osmotic resistance of the RBC from these patients. (F) Osmoscans from two patients with 
documented viral infection. These osmoscans are very similar to those shown in Fig. 2E. (G) 
Osmoscans from two patients with acquired membranopathies. One patient was 
undergoing cytotoxic treatment (green curve) and one patient had autoimmune hemolytic 
anemia (AIHA), shown in red. (H) Osmoscans from four patients with “possibly 
congenital” elevation of the hyperchromic RBC-fraction revealing unknown patterns. 
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We could not assign these osmoscans to a specific RBC membranopathy, despite all curves 
suggest some sort of membrane disorder. The green curve may fit to the pattern of a mild form 
of dehydrated stomatocytosis, with all characteristic points being shifted to hypoosmolality and 
the maximal deformability being only slightly diminished. The blue curve is the only curve of all 
measured samples that shows P’B at a higher osmolality as the mean of normal controls. The 
red curve possibly shows a borderline type of HS, with a slightly diminished osmotic fragility 
(Pmin) and a slightly diminished maximal deformability (Pmax). The brown curve shows a pattern 
reminiscent of a viral infection, except for the right shift of the left arm of the osmoscan. 
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